ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Abivax S.A.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026
$87.49−0.64 (-0.73%)
Close on Oct 19, 2026
Abivax statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Abivax | Industry median |
|---|---|---|
| Market Cap | €6.14B | €878.09M |
| Enterprise Value | €5.75B | €706.41M |
Income (trailing twelve months)
| Measure | Abivax | Industry median |
|---|---|---|
| Operating Income | -€246.06M | -€54.01M |
| Pretax Income | -€330.25M | -€47.40M |
| EBITDA | -€244.98M | -€42.85M |
| EPS (Diluted) | -4.83 EUR | -0.55 EUR |
Returns
| Measure | Abivax | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -63.0% | -23.8% |
Balance sheet
| Measure | Abivax | Industry median |
|---|---|---|
| Cash & Short-Term Investments | €387.99M | €199.29M |
| Net Cash (Debt) | €387.99M | €111.50M |
| Net Cash Per Share | 4.94 EUR | 1.53 EUR |
| Working Capital | €355.94M | €119.55M |
Financial position
| Measure | Abivax | Industry median |
|---|---|---|
| Current Ratio | 5.97 | 3.49 |
| Quick Ratio | 5.41 | 1.51 |
| Interest Coverage | -2.20 | -0.71 |
Cash flow (trailing twelve months)
| Measure | Abivax | Industry median |
|---|---|---|
| Operating Cash Flow | -€161.13M | -€42.16M |
| Capital Expenditures | -€142.00K | -€2.34M |
| Free Cash Flow | -€161.27M | -€52.90M |
| FCF Per Share | -2.05 EUR | -0.48 EUR |
Efficiency
| Measure | Abivax | Industry median |
|---|---|---|
| Employee Count | 69 | 304 |
Dividends and yields
| Measure | Abivax | Industry median |
|---|---|---|
| FCF Yield | -2.63% | -13.6% |
| Buyback Yield | -10.6% | -11.4% |
| Shareholder Yield | -10.6% | -11.4% |
Shares
| Measure | Abivax | Industry median |
|---|---|---|
| Shares Outstanding | 78,536,400 | 99,540,150 |
| Shares Change (YoY) | 10.3% | 5.61% |
| Shares Change (QoQ) | 0.66% | |
| Float | 75,000,600 | 78,574,400 |
| Shares Held by Insiders | 4.50% | 9.05% |
| Shares Held by Institutions | 70.1% | 13.8% |
Taxes
| Measure | Abivax | Industry median |
|---|---|---|
| Income Tax | €5.85M | €80.00K |
Scores
| Measure | Abivax | Industry median |
|---|---|---|
| Altman Z-Score | 37.56 | 1.13 |
Calculated by StockData from Abivax's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.